
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3155237810.1021/acsomega.9b02712ArticleMetal-Free C–H Functionalization of Allenamides:
An Access to Branched Allylic Esters Luo Guoli Liu Yongchun Ding Na Li Xiaoxiao *Zhao Zhigang *College of Chemistry and
Environmental
Protection Engineering, Southwest Minzu
University, Chengdu 610041, PR China* E-mail: lixiaoxiao.2005@163.com (X.L).* E-mail: zzg63129@163.com (Z.Z).09 09 2019 17 09 2019 4 12 15312 15322 22 08 2019 29 08 2019 Copyright © 2019 American Chemical Society2019American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A regioselective
acyloxylation with carboxylic acids at the proximal
carbon of allenamides by an N-iodosuccinimide-mediated
C–H functionalization is reported. The reaction proceeds rapidly,
is scalable to a gram scale, and displays a broad substrate scope,
providing an efficient and practical protocol for the synthesis of
branched allylic esters. Notably, protected amino acids were tolerated
under the reaction conditions and afforded allylic amino acid esters
in moderate yields.

document-id-old-9ao9b02712document-id-new-14ao-2019-02712pccc-price
==== Body
Introduction
Allylic esters have
garnered increasing attention because of their
presence in bioactive and medicinally relevant molecules.1 They are widely present in bioactive natural
products such as grandiuvarone A and albanol A (Figure 1), which are isolated from the barks of Uvaria grandiflora and Uvaria alba, respectively, and are known to exhibit antileishmanial, cytostatic,
and antiproliferative activities. Furthermore, branched allylic alcohols
and their ester derivatives are important building blocks in organic
synthesis.2

Figure 1 Bioactive molecules comprising
the allylic ester unit.

Traditional synthetic
methods for the preparation of allyl esters
involve the reaction of an acid or its derivatives (acyl chlorides
and anhydrides) with the corresponding allylic alcohols.3 However, these approaches suffer from limited
substrate scope and harsh reaction conditions. The transition-metal-catalyzed
direct oxidative esterification of allylic sp3 C–H
bonds has emerged as one of the most important strategies for the
synthesis of branched allylic esters and is an important alternative
to the traditional synthetic approaches. Several methodologies relying
on this approach have been reported for the synthesis of allylic esters.
Although palladium-,4 copper-,5 and iron-catalyzed6 esterifications of allylic sp3 C–H bonds have
been reported, they suffer from poor atom economy because of the necessity
for the use of stoichiometric equivalents of oxidants. An elegant
alternate approach for the synthesis of allylic esters via a redox-neutral
and atom-economic rhodium-catalyzed coupling of terminal alkynes with
carboxylic acids has been reported recently.7 Allenes are an easily accessible and remarkably stable substrate
class, and Yamamoto,8 Krische,9 and Breit10 reported
the palladium-, iridium-, and rhodium-catalyzed coupling of allenes
with carboxylic acids for synthesizing linear and branched allylic
esters. Although these methods are powerful synthetic transformations,
they require the use of transition metals, and in many cases the corresponding
ligands in the catalytic system, which make them expensive and less
ecofriendly. Considering these wide arrays of available approaches,
a metal-free approach to allylic sp3 C–H bond esterification
would obviate many of the aforementioned disadvantages. However, reports
on such metal-free allylic sp3 C–H esterification
are limited, and only one example using Bu4NI as a catalyst
was reported,11 which further highlights
the necessity for the development of a straightforward and low-cost
metal-free allylic sp3 C–H esterification protocol.

Allenamides have recently emerged as important synthetic intermediates
and participate in diverse and interesting transformations.12 We have reported the halogen-mediated intermolecular
coupling reactions of allenamides13 and
recently reported a related methodology for the metal-free synthesis
of allylic ethers by the regioselective alkoxylation of allenamides
with alcohols (Scheme 1a).14 However, this reaction required
the use of low-boiling alcohol nucleophiles as the reaction solvents,
which limited the substrate scope for the transformation and promoted
us to examine the allylic substitution using carboxylic acids as the
nucleophiles. We present herein a metal-free synthesis of branched
allylic esters with broad functional group tolerance by the N-iodosuccinimide (NIS)-mediated regioselective acyloxylation
at the proximal carbon of allenamides (Scheme 1b).

Scheme 1 NIS-Mediated Regioselective Alkoxylation
and Acyloxylation of Allenamides
Results
and Discussion
On the basis of our previous results on the
regioselective 1,2-additions
of alcohols to allenamides, we began our studies by exploring the
reaction between phenyl allenamide 1a and acetic acid 2a, and the optimization results of the study are summarized
in Table 1. Employing
the conditions from our previous study, upon treating phenyl allenamide 1a with 1.05 equiv of NIS in 3 mL of acetic acid, the acyloxylated
product 4aa was isolated in 86% yield (Table 1, entry 1). When the reaction
was performed with 1 equiv of acetic acid 2a in 3 mL
of dichloromethane (DCM), the branched allylic ester 4aa was obtained in 52% yield along with the linear allylic ester 5a in 20% yield (Table 1, entry 2). In an attempt to increase the nucleophilicity
of acetic acid 2a, 2 equiv of K2CO3 was added to the reaction mixture, which delivered the branched
allylic ester in 27% yield (Table 1, entry 3). After screening various equivalent ratios
of 1a and 2a, we found that the best regioselectivity
and yield of the branched allylic ester 4a were obtained
with the use of 6 equiv of 2a (Figure 2). Various iodine sources were evaluated
next, and compared to other iodine sources such as N-iodophthalimide (3d) and elemental iodine (3g), NIS proved to be the best choice for generating the target compound 4aa. Encouraged by these results, we examined the related N-haloimides for this transformation. When N-bromosuccinimide (3b) and N-bromophthalimide
(3e) were used in this reaction, the branched allylic
ester 4b was isolated in 50 and 47% yields, respectively
(Table 1, entries 5
and 8). N-Chlorosuccinimide (3c) and N-chlorophthalimide (3f) were less reactive
and delivered the corresponding product 4c in 55 and
34% yields, respectively. Subsequent solvent screening studies indicated
an increase in the yield of 4aa to 85% when CH3CN was used as the solvent, whereas 1,2-dichloroethane (DCE), CHCl3, toluene, and acetone were not as effective under the reaction
conditions (Table 1, entry 11–15). Furthermore, the control experiment (Table 1, entry 16) showed
that no acyloxylated product was obtained in the absence of NIS, revealing
the importance of the iodine sources.

Figure 2 Optimization of 1a/2a equiv ratio.

Table 1 Optimization
of Halogen-Mediated Acyloxylation
of Allenamide 1a with Acetic Acid 2aa
entry	1a/2a	halogen reagent	solvent	yield 4/5 (%)	
1b	 	3a	acetic acid	86/0	
2	1/1	3a	DCM	52/20	
3c	1/1	3a	DCM	27/0	
4d	1/6	3a	DCM	79/7	
5	1/6	3b	DCM	50/12	
6e	1/6	3c	DCM	55/22	
7f	1/6	3d	DCM	38/0	
8	1/6	3e	DCM	47/0	
9	1/6	3f	DCM	34/0	
10	1/6	3g	DCM	trace	
11	1/6	3a	DCE	62/16	
12	1/6	3a	CHCl3	69/23	
13	1/6	3a	CH3CN	85/0	
14	1/6	3a	toluene	69/5	
15	1/6	3a	acetone	77/10	
16	1/6	 	CH3CN	NR	
a Unless
stated otherwise, all reactions
were carried out with 1a (0.1 mmol) and 3 (0.105 mmol) in 3 mL of solvent at rt and are complete within 5
min.

b The reaction was carried
out with
3 mL of acetic acid as the solvent.

c 1.1 equiv K2CO3 was added.

d Best ratio of 1a/2a equiv.

e 1a was consumed within
1.5 h.

f 1a was
consumed within
9 h.

Employing the optimized
conditions (Table 1, entry 13), we investigated the scope of
the carboxylic acid substrates in the reaction (Table 2) and were pleased to find the efficient
formation of the desired products in good yields for all acids which
were evaluated. Aliphatic carboxylic acids (linear and branched) worked
well and afforded the desired allylic esters (4aa–4ae) in 62–85% yields. Similarly, cyclic carboxylic acids afforded
the branched allylic esters (4af–4ai) in 63–84%
yields. Furthermore, the sterically hindered adamantyl carboxylic
acid 2j was a suitable substrate and furnished the corresponding
product in 63% yield. In addition to the unsubstituted benzoic acid 2k, both electron-rich and electron-poor aromatic carboxylic
acids were suitable reaction partners (4al–4ap). The 2-methyl- and 3-fluoro-substituted benzoic acids also provided
the corresponding products 4aq and 4ar in
68% yield, respectively. The 2-naphthyl carboxylic acid 2s and cinnamic acid 2t were also tolerated under the
reaction conditions and afforded the desired allylic esters in 72
and 69% yields, respectively.

Table 2 NIS-Mediated Acyloxylation
of Allenamide 1a with Various Carboxylic Acidsa
a Conditions: 1a (0.1
mmol), 2a (0.6 mmol), NIS (0.105 mmol), CH3CN (3 mL), rt, within 5 min.

Having studied the scope of the carboxylic acids in this reaction,
we turned our attention to the investigation of the allenamide scope
(Table 3). Several para- and meta-substituted phenyl allenamides
were investigated first (1b–1h). Phenyl allenamides
bearing electron-rich substituents worked better in this reaction
and afforded the desired allylic esters 4ba and 4ca in 89 and 81% yields, respectively. The initial step of
this reaction was proposed to be the electrophilic halogenation between
the iodine electrophile and the π system of the allenamide.
The reactions with 3,5-dimethoxyl- and 2-naphthyl-substituted allenamides 1i and 1j proceeded smoothly and provided 4ia and 4ja in 72 and 78% yields, respectively.
Moreover, the molecular structure of the branched allylic ester 4ia was unambiguously determined by single-crystal X-ray diffraction
(Figure 3).15 Interestingly, when trimethyl phenyl allenamide
was used as the reactant, the linear allylic ester was isolated as
the sole product in 56% yield, possibly because of the increased steric
hindrance of the substrate. Next, benzyl allenamides 1k–1p were employed as substrates under optimized reaction conditions,
and the para-methyl- and bromo-substituted benzyl
allenamide 1l and 1p gave the allylic esters 4la and 4pa in 91 and 84% yields, respectively.
Both electron-rich and electron-poor benzyl allenamides 1k and 1m–1o furnished the desired products in
about 70% yields, exhibiting no obvious substituent effects. We investigated
next the reactivity of different allenamides bearing aliphatic substituents
under the optimized conditions. Both phenethyl- and n-butyl-substituted allenamides produced products 4qa and 4ra in 72 and 48% yields, respectively. The reaction
was also efficient when the tosyl group in the allenamides was substituted
with the acyl and mesyl amino protecting groups and delivered 4sa and 4ta in 74 and 81% yields, respectively.
Furthermore, 2-oxazolidinone allenamide 1u also provided
the corresponding product 4ua in 48% yield.

Figure 3 X-ray structure
of 4ia.

Table 3 NIS-Mediated
Acyloxylation of Various
Allenamides 1 with Acetic Acid 2aa
a Conditions: 1a (0.1
mmol), 2a (0.6 mmol), NIS (0.105 mmol), CH3CN (3 mL), rt, within 5 min.

To establish the practicality of this reaction, a gram-scale synthesis
of the branched allylic ester 4aa was carried out. When
1.42 g of allenamide 1a (5.0 mmol) was used, 1.95 g of
the desired product 4aa was obtained in 83% yield within
5 min, indicating the facile scalability of the transformation to
the gram scale without loss in efficiency (Scheme 2). To further demonstrate the potential applications
of this protocol, 1a was reacted with N-Boc-l-Phe, N-Ac-l-Phe, and N-Boc-l-Tyr, upon which the corresponding products
6, 7, and 8 were isolated in moderate yields in a 1:1 dr.

Scheme 2 Gram-Scale
Synthesis and Synthetic Applications
In summary, we demonstrated the first intermolecular addition of
carboxylic acids to the proximal carbon of allenamides toward the
formation of highly useful branched allylic esters under superior
regioselectivity by employing a simple and commercially available
iodine reagent. This reaction proceeds rapidly, is scalable up to
a gram scale, and tolerates a broad scope of substrates. Notably,
the protected amino acids were compatible and furnished the desired
allylic amino acid esters in moderate yields. A further exploration
of potential applications and studies to extend this interesting synthetic
methodology is currently underway.

Experimental Section
General
Conditions
All reactions were performed using
Schlenk tubes, septa, and syringes without the protection of nitrogen.
Tetrahydrofuran, toluene, DCM, and DCE were freshly distilled over
sodium/benzophenone and calcium hydride, respectively. Commercial
reagents were used as supplied or were purified by standard techniques
where necessary. Column chromatography was performed using a 200–300
mesh silica gel (Qingdao Haiyang Chemical Co., Ltd., silica gel F254)
with an appropriate solvent system, as determined by thin-layer chromatography
(TLC) analysis using UV light and KMnO4 stain to visualize
the reaction components. Melting points were determined using a WRS-1B
digital melting point instrument. IR spectra were recorded on a Nicoletisso
Fourier transform infrared spectrometer using KBr disks. Unless otherwise
noted, nuclear magnetic resonance spectra were recorded at room temperature
on an Agilent 400 MHz spectrometer using CDCl3 as the solvent
and tetramethylsilane (TMS) as the internal reference. Chemical shifts
for 13C nuclear magnetic resonance (NMR) spectra were recorded
in parts per million relative to TMS using the central peak of deuterochloroform
(77.0 ppm) as the internal standard (see Supporting Information).
High-resolution mass spectrometry (HRMS) was performed using a Bruker
Daltonics Bio time-of-flight (TOF) mass spectrometer.

Allenamides 1a–1u were prepared according to the published methods.16 Carboxylic acids were obtained commercially
and used without further purification.

General Procedure for NIS-Mediated
Acyloxylation of Allenamide 1a with Acetic Acid 2a
To a Schlenk
tube were added allenamide 1a (0.1 mmol, 28.5 mg), acetic
acid 2a (6.0 equiv, 34 μL), NIS (1.05 equiv, 23.5
mg), and CH3CN (anhydrous, 3 mL). Then, the reaction mixture
was stirred at room temperature (rt) for 5 min until the complete
consumption of the starting material as monitored by TLC. The mixture
was then washed with saturated sodium bicarbonate solution (5 mL),
extracted with DCM (3 mL × 2), and dried over anhydrous Na2SO4. The concentration of the reaction mixture
in vacuo followed by purification through flash chromatography on
a silica gel column (hexane/EtOAc = 5/1 as the eluent) afforded 4aa (40.0 mg, 85% yield) as a white solid.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Acetate (4aa)
Yield 85% (40.0 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 103.6–108.2 °C; IR (neat,
cm–1): 3452, 1660, 1630, 1170, 1090, 745, 702; 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.1 Hz, 2H), 7.36 (t, J = 7.1 Hz, 1H),
7.31 (d, J = 7.7 Hz, 2H), 7.26–7.24 (m, 5H),
6.03 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 1.99 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ 168.1,
144.0, 136.1, 134.5, 131.5, 129.2, 129.1, 128.9, 128.6, 128.1, 101.2,
84.9, 21.6, 20.6; HRMS (ESI) m/z: calcd for C18H18INO4SNa+ (M + Na)+, 493.9893; found, 493.9899.

2-Bromo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Acetate (4b)
Yield 50% (21.2 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 120.5–120.9 °C; IR (neat,
cm–1): 3468, 2935, 2378, 1760, 1365, 1249, 1170,
1088, 700, 666; 1H NMR (400 MHz, CDCl3): δ
7.43 (d, J = 7.9 Hz, 2H), 7.28–7.23 (m, 1H),
7.22–7.12 (m, 5H), 7.10 (d, J = 7.5 Hz, 2H),
5.45 (s, 1H), 5.32 (s, 1H), 2.33 (s, 3H), 1.90 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1,
144.0, 136.2, 134.5, 131.4, 129.3, 129.2, 128.6, 128.0, 125.0, 120.5,
82.9, 21.6, 20.6. HRMS (ESI) m/z: calcd for C18H18BrNO4SNa+ (M + Na)+, 446.0032: found, 446.0038.

2-Chloro-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Acetate (4c)
Yield 55% (20.8 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 103.4–104.3 °C; IR (neat,
cm–1): 3480, 2935, 2376, 1761, 1353, 1167, 1091,
700, 667; 1H NMR (400 MHz, CDCl3): δ 7.44
(d, J = 8.2 Hz, 2H), 7.26 (t, J =
7.3 Hz, 1H), 7.19 (t, J = 7.5 Hz, 2H), 7.15 (d, J = 8.9 Hz, 3H), 7.07 (d, J = 7.6 Hz, 2H),
5.09 (s, 1H), 5.02 (s, 1H), 2.33 (s, 3H), 1.91 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1,
144.0, 136.3, 134.5, 134.4, 131.4, 129.3, 129.2, 128.6, 128.0, 116.0,
81.8, 21.6, 20.7. HRMS (ESI) m/z: calcd for C18H18Cl4SNa+ (M + Na)+, 402.0537; found, 402.0540.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Propionate (4ab)
Yield 77% (37.5 mg); Rf = 0.31 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 117.7–118.7 °C;
IR (neat, cm–1): 3463, 2938, 2383, 1642, 1360, 1081,
745; 1H NMR (400 MHz, CDCl3): δ 7.45 (d, J = 7.7 Hz, 2H), 7.31–7.27 (m, 1H), 7.24 (d, J = 7.4 Hz, 2H), 7.21–7.16 (m, 5H), 5.94 (s, 1H),
5.64 (s, 1H), 2.36 (s, 3H), 2.24–2.10 (m, 2H), 1.03 (t, J = 7.5 Hz, 3H); 13C{1H} NMR (100
MHz, CDCl3): δ 171.4, 144.0, 136.2, 134.5, 131.5,
129.3, 129.1, 128.8, 128.5, 128.1, 101.4, 84.7, 27.3, 21.6, 8.7; HRMS
(ESI) m/z: calcd for C19H20INO4SNa+ (M + Na)+, 508.0050; found, 508.0051.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Butyrate (4ac)
Yield 67% (33.5 mg); Rf = 0.12 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 97.7–99.1 °C;
IR (neat, cm–1): 3453, 1646, 1271, 1168, 745, 705; 1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 7.9 Hz, 2H), 7.38–7.34 (m, 1H), 7.31 (d, J = 7.6 Hz, 2H), 7.27 (m, 4H), 7.24 (s, 1H), 6.01 (s, 1H),
5.71 (s, 1H), 2.43 (s, 3H), 2.20 (dd, J = 16.1, 8.0
Hz, 2H), 1.61 (dd, J = 14.7, 7.3 Hz, 2H), 0.94 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (100
MHz, CDCl3): δ 170.7, 144.0, 136.2, 134.5, 131.5,
129.3, 129.1, 128.8, 128.5, 128.1, 101.5, 84.7, 35.7, 21.6, 18.00,
13.7; HRMS (ESI) m/z: calcd for
C20H22INO4SNa+ (M + Na)+, 522.0206; found, 522.0209.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Isobutyrate (4ad)
Yield 62% (30.7 mg); Rf = 0.5 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 101.7–102.0 °C; IR (neat,
cm–1): 3432, 3141, 1647, 1625, 1406, 1075, 600,
574; 1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 8.2 Hz, 2H), 7.39–7.35 (m, 1H), 7.31 (t, J = 7.4 Hz, 2H), 7.27–7.23 (m, 4H), 6.00 (s, 1H),
5.71 (s, 1H), 2.46 (q, J = 7.0 Hz), 2.42 (s, 3H),
1.13 (s, 3H), 1.11 (s, 3H); 13C{1H} NMR (100
MHz, CDCl3): δ 173.9, 144.0, 136.3, 134.5, 131.6,
129.3, 129.1, 128.7, 128.6, 128.1, 101.7, 84.6, 33.8, 21.6, 18.7,
18.5; HRMS (ESI) m/z: calcd for
C20H22INO4SNa+ (M + Na)+, 522.0206; found, 522.0208.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Nonanoate (4ae)
Yield 66% (37.5 mg); Rf = 0.55 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 96.2–97.5 °C;
IR (neat, cm–1): 3463, 2937, 2372, 2350, 1757, 1172,
1079, 744, 672; 1H NMR (400 MHz, CDCl3): δ
7.53 (d, J = 7.7 Hz, 2H), 7.35 (d, J = 6.5 Hz, 1H), 7.31 (d, J = 7.4 Hz, 2H), 7.26–7.23
(m, 5H), 6.01 (s, 1H), 5.71 (s, 1H), 2.43 (s, 3H), 2.27–2.13
(m, 2H), 1.59–1.52 (m, 2H), 1.28 (br, 10H), 0.89 (t, J = 6.5 Hz, 3H); 13C{1H} NMR (100
MHz, CDCl3): δ 170.9, 143.9, 136.3, 134.6, 131.6,
129.3, 129.1, 128.8, 128.6, 128.1, 101.6, 84.7, 33.9, 31.8, 29.2,
29.1, 29.08, 24.5, 22.6, 21.6, 14.1; HRMS (ESI) m/z: calcd for C25H32INO4SNa+ (M + Na)+, 592.0989; found, 592.0988.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Cyclopropanecarboxylate (4af)
Yield 84% (41.7
mg); Rf = 0.28 (SiO2; hexanes/ethyl acetate, 10:1); white solid; mp 137.9–138.8
°C; IR (neat, cm–1): 3464, 2257, 1662, 1641,
1076, 744; 1H NMR (400 MHz, CDCl3): δ
7.52 (d, J = 7.6 Hz, 2H), 7.36 (d, J = 6.9 Hz, 1H), 7.32 (d, J = 7.0 Hz, 2H), 7.29–7.24
(m, 5H), 6.05 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 1.54–1.51
(m, 1H), 1.07–1.06 (m, 1H), 0.95–0.90 (m, 3H); 13C{1H} NMR (100 MHz, CDCl3): δ
172.1, 143.9, 136.1, 134.5, 131.5, 129.3, 129.1, 128.9, 128.5, 128.1,
101.3, 84.8, 21.6, 12.5, 8.9, 8.7; HRMS (ESI) m/z: calcd for C20H20INO4SNa+ (M + Na)+, 520.0050; found, 520.0046.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Cyclobutanecarboxylate (4ag)
Yield 63% (32.2
mg); Rf = 0.34 (SiO2; hexanes/ethyl acetate, 10:1); white solid; mp 113.9–114.6
°C; IR (neat, cm–1): 3433, 2936, 2383, 1635,
1363, 1166, 1085, 702; 1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 8.1 Hz, 2H), 7.38–7.34
(m, 1H), 7.31 (d, J = 7.7 Hz, 2H), 7.29–7.23
(m, 5H), 6.00 (s, 1H), 5.71 (s, 1H), 3.07–2.98 (m, 2H), 2.43
(s, 3H), 2.22–2.12 (m, 4H), 2.01–1.94 (m, 1H), 1.90–1.86
(m, 1H); 13C{1H} NMR (100 MHz, CDCl3): δ 172.4, 144.0, 136.2, 134.5, 131.5, 129.3, 129.1, 128.8,
128.6, 128.1, 101.6, 84.5, 37.5, 25.0, 24.8, 21.6, 18.4; HRMS (ESI) m/z: calcd for C21H22INO4SNa+ (M + Na)+, 534.0206; found,
534.0208.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Cyclopentanecarboxylate (4ah)
Yield 63% (33.0
mg); Rf = 0.16 (SiO2; hexanes/ethyl acetate, 10:1); colorless liquid; IR (neat,
cm–1): 3471, 2934, 1711, 1604, 1500, 1355, 1094,
744; 1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 7.5 Hz, 2H), 7.36 (d, J = 7.1 Hz, 1H),
7.31 (t, J = 7.4 Hz, 2H), 7.28–7.24 (m, 4H),
7.23 (s, 1H), 6.01 (s, 1H), 5.71 (s, 1H), 2.66–2.58 (m, 1H),
2.42 (s, 3H), 1.87–1.79 (m, 2H), 1.73–1.65 (m, 4H),
1.61–1.56 (m, 2H). 13C{1H} NMR (100 MHz,
CDCl3): δ 173.6, 143.9, 136.3, 134.6, 131.6, 129.3,
129.1, 128.7, 128.6, 128.1, 101.8, 84.5, 43.4, 29.8, 29.4, 25.8, 25.7,
21.6. HRMS (ESI) m/z: calcd for
C22H24INO4SNa+ (M + Na)+, 548.03630; found, 548.0364.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Cyclohexanecarboxylate (4ai)
Yield 68% (36.6
mg); Rf = 0.33 (SiO2; hexanes/ethyl acetate, 10:1); white solid; mp 107.5–107.9
°C; IR (neat, cm–1): 3458, 2378, 1678, 1641,
1270, 1080, 744; 1H NMR (400 MHz, CDCl3): δ
7.54 (d, J = 8.2 Hz, 2H), 7.39–7.35 (m, 1H),
7.32 (t, J = 7.4 Hz, 2H), 7.27–7.23 (m, 5H),
6.00 (s, 1H), 5.70 (s, 1H), 2.43 (s, 3H), 2.20–2.15 (m, 1H),
1.85–1.73 (m, 4H), 1.67–1.62 (m, 1H), 1.38–1.23
(m, 5H). 13C{1H} NMR (100 MHz, CDCl3): δ 173.0, 143.9, 136.4, 134.6, 131.5, 129.3, 129.1, 128.8,
128.6, 128.1, 101.7, 84.6, 42.8, 28.8, 28.6, 25.6, 25.3, 25.26, 21.6.
HRMS (ESI) m/z: calcd for C23H26INO4SNa+ (M + Na)+, 562.0519; found, 562.0519.

(3R,5R,7R)-2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Adamantane-1-carboxylate (4aj)
Yield 63% (38.0
mg); Rf = 0.26 (SiO2; hexanes/ethyl acetate, 10:1); white solid; mp 99.7–101.2
°C; IR (neat, cm–1): 3474, 2929, 2368, 1661,
1630, 1171, 1055, 743; 1H NMR (400 MHz, CDCl3): δ 7.56 (d, J = 8.1 Hz, 2H), 7.34–7.28
(m, 5H), 7.26–7.24 (m, 3H), 5.99 (s, 1H), 5.70 (s, 1H), 2.42
(s, 3H), 2.00 (s, 3H), 1.80–1.70 (m, 10H), 1.67 (br, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ
174.6, 143.9, 136.6, 134.6, 131.6, 129.4, 129.1, 128.7, 128.6, 128.1,
101.9, 84.5, 40.6, 38.7, 36.3, 27.7, 21.6. HRMS (ESI) m/z: calcd for C27H30INO4SNa+ (M + Na)+, 614.0832; found, 614.0836.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Benzoate (4ak)
Yield 85% (45.3 mg); Rf = 0.28 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 120.2–123.1 °C;
IR (neat, cm–1): 3454, 2384, 1733, 1635, 1271, 1067,
707, 573; 1H NMR (400 MHz, CDCl3): δ 7.82
(d, J = 7.4 Hz, 2H), 7.61 (t, J =
7.2 Hz, 1H), 7.52–7.46 (m, 4H), 7.43 (d, J = 7.8 Hz, 2H), 7.40–7.36 (m, 4H), 7.03 (d, J = 7.9 Hz, 2H), 6.09 (s, 1H), 5.75 (s, 1H), 2.25 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 163.9,
143.9, 136.0, 134.7, 133.7, 131.5, 129.7, 129.3, 129.2, 128.7, 128.5,
128.0, 100.9, 85.8, 21.4. HRMS (ESI) m/z: calcd for C23H20INO4SNa+ (M + Na)+, 556.0050; found, 556.0049.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
4-Methylbenzoate (4al)
Yield 74% (40.4 mg); Rf = 0.29 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 141.3–142.1 °C;
IR (neat, cm–1): 3460, 2382, 1635, 1272, 1067, 754,
580; 1H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 7.7 Hz, 2H), 7.50 (s, 1H), 7.47 (d, J = 7.8 Hz, 2H), 7.42–7.34 (m, 5H), 7.24 (d, J = 7.5 Hz, 2H), 7.03 (d, J = 7.5 Hz, 2H), 6.08 (s,
1H), 5.73 (s, 1H), 2.44 (s, 3H), 2.26 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 164.0, 144.6,
143.8, 135.9, 134.7, 131.5, 129.7, 129.3, 129.2, 129.14, 129.1, 128.6,
127.9, 125.8, 101.0, 85.6, 21.8, 21.4. HRMS (ESI) m/z: calcd for C24H22INO4SNa+ (M + Na)+, 570.0206; found, 570.0204.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
4-Methoxybenzoate (4am)
Yield 70% (39.2 mg); Rf = 0.2 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 139.6–139.9 °C; IR (neat,
cm–1): 3465, 2936, 2381, 1725, 1266, 1170, 1064,
744, 699; 1H NMR (400 MHz, CDCl3): δ 7.78
(d, J = 8.0 Hz, 2H), 7.48–7.46 (m, 3H), 7.38–7.35
(m, 5H), 7.04 (d, J = 7.8 Hz, 2H), 6.91 (d, J = 8.0 Hz, 2H), 6.08 (s, 1H), 5.73 (s, 1H), 3.89 (s, 3H),
2.27 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 163.9, 163.6, 143.8, 136.0, 134.7, 131.8, 131.5,
129.3, 129.1, 129.07, 128.6, 128.0, 120.9, 113.7, 101.2, 85.5, 55.5,
21.5. HRMS (ESI) m/z: calcd for
C24H22INO4SNa+ (M + Na)+, 586.0161; found, 586.0170.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
4-Fluorobenzoate (4an)
Yield 68% (37.6 mg); Rf = 0.4 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 115.9–116.3 °C; IR (neat,
cm–1): 3434, 3143, 1625, 1406, 1069, 575, 476; 1H NMR (400 MHz, CDCl3): δ 7.87 (d, J = 5.4 Hz, 1H), 7.84 (d, J = 5.4 Hz, 1H),
7.49 (s, 2H), 7.47 (s, 1H), 7.40–7.32 (m, 5H), 7.12 (t, J = 8.6 Hz, 2H), 7.06 (d, J = 8.2 Hz, 2H),
6.08 (t, J = 1.9 Hz, 1H), 5.75 (s, 1H), 2.29 (s,
3H). 13C{1H} NMR (101 MHz, CDCl3):
δ 166.1 (d, J = 254.3 Hz), 163.0, 143.9, 136.0,
134.6, 132.3 (d, J = 9.4 Hz), 131.5, 129.3, 129.24,
129.2, 128.7, 128.0, 124.9 (d, J = 3.0 Hz), 115.8
(d, J = 22.0 Hz), 100.8, 85.9, 21.4. HRMS (ESI) m/z: calcd for C23H19FINO4SNa+ (M + Na)+, 573.9956; found,
573.9958.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
4-Chlorobenzoate (4ao)
Yield 65% (36.7 mg); Rf = 0.38 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 98.3–99.7 °C;
IR (neat, cm–1): 3465, 2276, 1660, 1648, 1271, 1059,
744, 707; 1H NMR (400 MHz, CDCl3): δ 7.77
(d, J = 8.5 Hz, 2H), 7.49 (s, 2H), 7.47 (s, 1H),
7.44–7.43 (m, 1H), 7.42–7.40 (m, 1H), 7.39–7.38
(m, 1H), 7.36 (s, 1H), 7.35–7.31 (m, 3H), 7.06 (d, J = 8.2 Hz, 2H), 6.08 (s, 1H), 5.75 (s, 1H), 2.29 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
163.1, 144.0, 140.3, 136.0, 134.6, 131.5, 131.0, 129.3, 129.2, 128.9,
128.7, 128.0, 127.1, 100.7, 86.0, 21.4. HRMS (ESI) m/z: calcd for C23H19ClINO4SNa+ (M + Na)+, 589.9660; found, 589.9664.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
4-Bromobenzoate (4ap)
Yield 69% (41.9 mg); Rf = 0.33 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 112.1–112.8 °C;
IR (neat, cm–1): 3464, 2286, 1647, 1271, 1070, 745,
706; 1H NMR (400 MHz, CDCl3): δ 7.68 (d, J = 8.4 Hz, 2H), 7.59 (d, J = 7.5 Hz, 2H),
7.49 (s, 2H), 7.47 (s, 1H), 7.42–7.31 (m, 5H), 7.06 (d, J = 7.7 Hz, 2H), 6.07 (s, 1H), 5.76 (s, 1H), 2.29 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
163.3, 144.0, 135.9, 134.5, 131.9, 131.4, 131.1, 129.3, 129.27, 129.25,
128.9, 128.7, 127.9, 127.5, 100.6, 86.0, 21.5. HRMS (ESI) m/z: calcd for C23H19BrINO4SNa+ (M + Na)+, 633.9155;
found, 633.9157.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
2-Methylbenzoate (4aq)
Yield 68% (37.0 mg); Rf = 0.38 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 96.6–96.9 °C;
IR (neat, cm–1): 3456, 2935, 2383, 1635, 1049, 754,
702; 1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 7.8 Hz, 2H), 7.47–7.43 (m, 3H), 7.40–7.33
(m, 5H), 7.29 (d, J = 7.2 Hz, 1H), 7.18 (t, J = 7.2 Hz, 1H), 7.09 (d, J = 7.5 Hz, 2H),
6.11 (s, 1H), 5.75 (s, 1H), 2.63 (s, 3H), 2.30 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 164.3,
143.9, 141.6, 136.1, 134.7, 132.7, 132.0, 131.5, 130.1, 129.3, 129.1,
129.09, 128.6, 127.9, 127.5, 125.6, 101.3, 85.6, 21.8, 21.5. HRMS
(ESI) m/z: calcd for C24H22INO4SNa+ (M + Na)+, 570.0206; found, 570.0205.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
3-Fluorobenzoate (4ar)
Yield 68% (37.4 mg); Rf = 0.31 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 92.1–92.7 °C;
IR (neat, cm–1): 3453, 2928, 2375, 1633, 1081, 756; 1H NMR (400 MHz, CDCl3): δ 7.66 (d, J = 7.7 Hz, 1H), 7.49 (s, 2H), 7.47 (s, 1H), 7.44–7.39
(m, 4H), 7.37–7.30 (m, 5H), 7.07 (d, J = 7.9
Hz, 2H), 6.07 (s, 1H), 5.76 (s, 1H), 2.29 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 162.9, 162.8,
162.4 (d, J = 246.5 Hz), 144.1, 135.9, 134.5, 131.5,
130.3, 130.2, 129.4, 129.3 (d, J = 2.4 Hz), 128.7,
127.9, 125.5 (d, J = 3.1 Hz), 120.8 (d, J = 21.2 Hz), 116.4 (d, J = 23.1 Hz), 100.5, 86.2,
21.4. HRMS (ESI) m/z: calcd for
C23H19FINO4SNa+ (M + Na)+, 573.9956; found, 573.9959.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
2-Naphthoate (4as)
Yield 72% (41.4 mg); Rf = 0.24 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 121.8–122.3 °C;
IR (neat, cm–1): 3452, 2928, 2366, 1634, 1025, 724,
668; 1H NMR (400 MHz, CDCl3): δ 8.30 (s,
1H), 7.91–7.86 (m, 3H), 7.82 (d, J = 8.5 Hz,
1H), 7.64 (t, J = 7.3 Hz, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.56 (s, 1H), 7.48 (d, J = 8.0 Hz,
2H), 7.44–7.38 (m, 5H), 6.97 (d, J = 7.9 Hz,
2H), 6.14 (s, 1H), 5.76 (s, 1H), 2.08 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 164.1, 143.9,
136.0, 135.7, 134.7, 132.2, 131.5, 131.46, 129.32, 129.3, 129.2, 129.2,
128.8, 128.7, 128.3, 127.9, 127.8, 126.9, 125.8, 124.9, 100.9, 86.0,
21.3. HRMS (ESI) m/z: calcd for
C27H22INO4SNa+ (M + Na)+, 606.0206; found, 606.0207.

2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
Cinnamate (4at)
Yield 69% (38.5 mg); Rf = 0.36 (SiO2;
hexanes/ethyl acetate, 10:1); white solid; mp 134.0–135.2 °C;
IR (neat, cm–1): 3462, 2936, 2382, 1758, 1634, 1366,
1215, 1013, 716; 1H NMR (400 MHz, CDCl3): δ
7.56 (d, J = 16.0 Hz, 1H), 7.51–7.49 (m, 4H),
7.43–7.41 (m, 3H), 7.38–7.36 (m, 2H), 7.35–7.31
(m, 4H), 7.15 (d, J = 7.9 Hz, 2H), 6.25 (d, J = 16.0 Hz, 1H), 6.08 (s, 1H), 5.73 (s, 1H), 2.27 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
164.1, 146.6, 143.9, 136.0, 134.6, 133.7, 131.5, 130.9, 129.3, 129.1,
129.0, 128.6, 128.2, 128.1, 116.2, 101.0, 85.3, 21.4. HRMS (ESI) m/z: calcd for C25H22INO4SNa+ (M + Na)+, 582.0206; found,
582.0208.

2-Iodo-1-(4-methyl-N-(p-tolyl)phenylsulfonamido)allyl
Acetate (4ba)
Yield 89% (43.0 mg); Rf = 0.28 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 112.3–113.4 °C; IR (neat,
cm–1): 3463, 2934, 2382, 1755, 1635, 1217, 1087,
744; 1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 7.7 Hz, 2H), 7.26 (s, 2H), 7.24 (s, 1H), 7.10 (br, 4H),
6.03 (s, 1H), 5.72 (s, 1H), 2.44 (s, 3H), 2.35 (s, 3H), 1.98 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
168.1, 143.9, 139.2, 136.1, 131.7, 131.1, 129.2, 128.8, 128.1, 101.3,
84.9, 21.6, 21.2, 20.5. HRMS (ESI) m/z: calcd for C19H20INO4SNa+ (M + Na)+, 508.0050; found, 508.0048.

2-Iodo-1-(N-(4-methoxyphenyl)-4-methylphenylsulfonamido)allyl
Acetate (4ca)
Yield 81% (40.6 mg); Rf = 0.2 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 142.1–142.3 °C; IR (neat,
cm–1): 3469, 2384, 1634, 1270, 1072, 749; 1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 5.2 Hz, 2H), 7.25 (d, J = 7.2 Hz, 4H), 7.14 (d, J = 6.3 Hz, 1H), 6.80 (d, J = 7.2 Hz, 2H),
6.03 (s, 1H), 5.74 (s, 1H), 3.81 (s, 3H), 2.44 (s, 3H), 1.99 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
168.1, 159.9, 143.9, 136.1, 132.7, 129.3, 128.8, 128.1, 126.9, 113.7,
101.5, 85.0, 55.3, 21.6, 20.6. HRMS (ESI) m/z: calcd for C19H20INO5SNa+ (M + Na)+, 523.9999; found, 523.9996.

1-(N-(4-Fluorophenyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4da)
Yield 66% (32.4 mg); Rf = 0.22 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 108.2–109.4 °C; IR (neat,
cm–1): 3468, 2965, 2376, 1660, 1213, 1011, 740; 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.1 Hz, 2H), 7.27 (d, J = 2.8 Hz, 2H),
7.26–7.22 (m, 3H), 7.21 (d, J = 5.0 Hz, 1H),
6.99 (t, J = 8.5 Hz, 2H), 6.04 (s, 1H), 5.75 (s,
1H), 2.44 (s, 3H), 2.00 (s, 3H). 13C{1H} NMR
(100 MHz, CDCl3): δ 168.0, 162.7 (d, J = 248.3 Hz), 144.3, 135.8, 133.3 (d, J = 8.8 Hz),
130.3 (d, J = 3.2 Hz), 129.4, 129.0, 128.0, 115.6
(d, J = 22.5 Hz), 101.1, 84.8, 21.6, 20.5. HRMS (ESI) m/z: calcd for C18H17FINO4SNa+ (M + Na)+, 511.9799; found,
511.9798.

1-(N-(4-Chlorophenyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4ea)
Yield 73% (36.9 mg); Rf = 0.24 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 129.3–130.7 °C; IR (neat,
cm–1): 3448, 2932, 2378, 1643, 1273, 1014, 752; 1H NMR (400 MHz, CDCl3): δ 7.44 (d, J = 8.0 Hz, 2H), 7.22–7.16 (m, 5H), 7.11 (d, J = 8.5 Hz, 2H), 5.98 (s, 1H), 5.67 (s, 1H), 2.37 (s, 3H),
1.91 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 167.9, 144.3, 135.7, 135.2, 133.0, 132.6, 129.4,
129.1, 128.8, 128.0, 100.9, 84.8, 21.6, 20.5. HRMS (ESI) m/z: calcd for C18H17ClINO4SNa+ (M + Na)+, 527.9503; found, 527.9506.

1-(N-(4-Bromophenyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4fa)
Yield 71% (39.0 mg); Rf = 0.28 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 145.6–145.9 °C; IR (neat,
cm–1): 3475, 1936, 2368, 1758, 1636, 1216, 1013,
753; 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.5 Hz, 2H),
7.27 (d, J = 3.0 Hz, 1H), 7.25 (d, J = 8.3 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 6.05 (s,
1H), 5.75 (s, 1H), 2.44 (s, 3H), 1.99 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 167.9, 144.3,
135.7, 133.6, 133.0, 131.9, 129.4, 129.2, 128.0, 123.5, 100.9, 84.7,
21.6, 20.5. HRMS (ESI) m/z: calcd
for C18H17BrINO4SNa+ (M
+ Na)+, 571.8999; found, 571.8998.

2-Iodo-1-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)allyl
Acetate (4ga)
Yield 72% (36.0 mg); Rf = 0.2 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 114.8–115.9 °C; IR (neat,
cm–1): 3458, 2935, 2388, 1617, 1172, 1087, 752,
569; 1H NMR (400 MHz, CDCl3): δ 7.55 (d, J = 5.4 Hz, 2H), 7.29–7.17 (m, 4H), 6.91 (d, J = 5.7 Hz, 1H), 6.83 (s, 2H), 6.05 (s, 1H), 5.73 (s, 1H),
3.76 (s, 3H), 2.44 (s, 3H), 1.98 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1, 159.3, 144.1,
136.0, 135.5, 129.3, 128.9, 128.1, 123.5, 117.3, 114.8, 100.9, 84.9,
55.3, 21.6, 20.5. HRMS (ESI) m/z: calcd for C19H20INO5SNa+ (M + Na)+, 523.9999; found, 523.9998.

1-(N-(3-Bromophenyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4ha)
Yield 62% (34.1 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 144.9–145.7 °C; IR (neat,
cm–1): 3466, 2377, 4642, 1272, 745; 1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 8.2 Hz, 2H), 7.50 (d, J = 8.1 Hz, 1H), 7.39 (s,
1H), 7.29 (d, J = 8.0 Hz, 2H), 7.24–7.16 (m,
3H), 6.08 (s, 1H), 5.77 (s, 1H), 2.45 (s, 3H), 2.00 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
167.9, 144.4, 135.8, 135.6, 134.4, 132.3, 130.1, 129.7, 129.4, 129.2,
128.0, 121.6, 100.7, 84.7, 21.6, 20.5. HRMS (ESI) m/z: calcd for C18H17BrINO4SNa+ (M + Na)+, 571.8998; found, 571.9004.

1-(N-(3,5-Dimethoxyphenyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4ia)
Yield 72% (38.3 mg); Rf = 0.10 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 81.5–82.3 °C; IR (neat,
cm–1): 3457, 2968, 2834, 1629, 1438, 1168, 1085,
772; 1H NMR (400 MHz, CDCl3): δ 7.59 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 5.5 Hz, 2H),
7.21 (s, 1H), 6.46 (s, 1H), 6.42 (s, 2H), 6.08 (s, 1H), 5.76 (s, 1H),
3.73 (s, 6H), 2.44 (s, 3H), 1.96 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1, 160.0, 144.1,
136.1, 136.0, 129.3, 129.1, 128.1, 109.8, 101.1, 100.8, 84.9, 55.4,
21.6, 20.5. HRMS (ESI) m/z: calcd
for C20H22INO6SNa+ (M
+ Na)+, 554.0105; found, 554.0108.

2-Iodo-1-(4-methyl-N-(naphthalen-2-yl)phenylsulfonamido)allyl
Acetate (4ja)
Yield 78% (40.5 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 123.3–125.2 °C; IR (neat,
cm–1): 3456, 2924, 2384, 1643, 1272, 1084, 752; 1H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 7.3 Hz, 1H), 7.80 (d, J = 7.5 Hz, 1H),
7.76 (d, J = 9.9 Hz, 2H), 7.54–7.49 (m, 4H),
7.34 (br, 2H), 7.25 (d, J = 8.2 Hz, 2H), 6.03 (s,
1H), 5.66 (s, 1H), 2.45 (s, 3H), 2.04 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1, 144.1,
136.1, 133.1, 132.9, 131.9, 130.8, 129.3, 129.0, 128.6, 128.4, 128.3,
128.1, 127.6, 127.1, 126.3, 101.0, 85.2, 21.6, 20.7. HRMS (ESI) m/z: calcd for C22H20INO4SNa+ (M + Na)+, 544.0050; found,
544.0046.

1-(N-Benzyl-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4ka)
Yield 69% (33.4 mg); Rf = 0.24 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 86.9–88.9 °C; IR (neat,
cm–1): 3463, 2968, 2374, 1662, 1164, 1056, 738; 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.2 Hz, 2H), 7.34–7.31 (m, 2H), 7.24–7.22
(m, 5H), 6.90 (s, 1H), 6.37 (s, 1H), 5.98 (s, 1H), 4.51 (d, J = 15.9 Hz, 1H), 4.40 (d, J = 15.9 Hz,
1H), 2.41 (s, 3H), 1.84 (s, 3H). 13C{1H} NMR
(100 MHz, CDCl3): δ 168.1, 143.8, 136.5, 136.3, 129.4,
129.2, 128.9, 128.0, 127.8, 127.4, 102.5, 84.7, 48.0, 21.5, 20.3.
HRMS (ESI) m/z: calcd for C19H20INO4SNa+ (M + Na)+, 508.0050; found, 508.0052.

1-(N-Benzyl-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4la)
Yield 91% (45.6 mg); Rf = 0.35 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 109.9–110.5 °C; IR (neat,
cm–1): 3439, 2965, 2385, 1756, 1634, 1165, 1101,
744; 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.0 Hz, 2H), 7.25–7.18 (m, 4H), 7.05 (d, J = 7.5 Hz, 2H), 6.89 (s, 1H), 6.38 (s, 1H), 5.98 (s, 1H),
4.46 (d, J = 15.8 Hz, 1H), 4.35 (d, J = 15.9 Hz, 1H), 2.41 (s, 3H), 2.32 (s, 3H), 1.85 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1,
143.7, 137.0, 136.5, 133.1, 129.4, 129.2, 128.9, 128.6, 127.8, 102.6,
84.7, 47.8, 21.5, 21.1, 20.3. HRMS (ESI) m/z: calcd for C20H22INO4SNa+ (M + Na)+, 522.0206; found, 522.0208.

2-Iodo-1-(N-(4-methoxybenzyl)-4-methylphenylsulfonamido)allyl
Acetate (4ma)
Yield 67% (35.0 mg); Rf = 0.16 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 114.2–116.2 °C; IR (neat,
cm–1): 3469, 2939, 2383, 1629, 1166, 1028, 756,
669; 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 7.9 Hz, 2H), 7.18 (d, J = 4.4 Hz, 1H),
7.15 (d, J = 7.3 Hz, 3H), 6.81 (s, 1H), 6.69 (d, J = 8.2 Hz, 2H), 6.30 (s, 1H), 5.91 (s, 1H), 4.36 (d, J = 15.6 Hz, 1H), 4.27 (d, J = 15.7 Hz,
1H), 3.72 (s, 3H), 2.33 (s, 3H), 1.79 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.1, 159.0,
143.7, 136.6, 130.4, 129.3, 129.1, 128.2, 127.7, 113.3, 102.7, 84.7,
55.2, 47.5, 21.5, 20.3. HRMS (ESI) m/z: calcd for C20H22INO5SNa+ (M + Na)+, 538.0156; found, 538.0159.

1-(N-(4-Fluorobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4na)
Yield 68% (34.2 mg); Rf = 0.18 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 58.4–59.6 °C; IR (neat,
cm–1): 3458, 2382, 1635, 1273, 1056, 752; 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.1 Hz, 2H), 7.34–7.30 (m, 2H), 7.26 (s, 1H), 7.24 (s,
1H), 6.93 (t, J = 8.6 Hz, 2H), 6.88 (s, 1H), 6.37
(s, 1H), 5.97 (s, 1H), 4.44 (d, J = 15.9 Hz, 1H),
4.38 (d, J = 15.9 Hz, 1H), 2.41 (s, 3H), 1.85 (s,
3H). 13C{1H} NMR (100 MHz, CDCl3):
δ 167.9, 162.1 (d, J = 244.6 Hz), 143.9, 136.3,
132.0 (d, J = 3.2 Hz), 131.0, 130.7, 129.4, 129.2,
127.6 (d, J = 12.5 Hz), 114.9, 114.7, 102.5, 84.6,
47.2, 21.5, 20.2. HRMS (ESI) m/z: calcd for C19H19FINO4SNa+ (M + Na)+, 525.9956; found, 525.9959.

1-(N-(4-Chlorobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4oa)
Yield 62% (32 mg); Rf = 0.28 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 135.6–136.2 °C; IR (neat,
cm–1): 3458, 2937, 2383, 1653, 1363, 1166, 1061,
1016, 822, 745; 1H NMR (400 MHz, CDCl3): δ
7.53 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 7.19–7.13 (m, 4H), 6.82 (s, 1H), 6.30 (s,
1H), 5.91 (s, 1H), 4.35 (d, J = 16.0 Hz, 1H), 4.27
(d, J = 16.0 Hz, 1H), 2.35 (s, 3H), 1.79 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
167.9, 144.1, 136.2, 135.4, 131.0, 130.6, 129.5, 129.3, 127.7, 121.4,
102.3, 84.7, 47.3, 21.5, 20.3. HRMS (ESI) m/z: calcd for C19H19ClINO4SNa+ (M + Na)+, 541.9660; found, 541.9660.

1-(N-(4-Bromobenzyl)-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4pa)
Yield 84% (47.1 mg); Rf = 0.21 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 112.7–114.6 °C; IR (neat,
cm–1): 3457, 2936, 2835, 1758, 1361, 1165, 745,
699; 1H NMR (400 MHz, CDCl3): δ 7.61 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.1 Hz, 2H),
7.26–7.20 (m, 4H), 6.89 (s, 1H), 6.38 (s, 1H), 5.98 (s, 1H),
4.43 (d, J = 16.0 Hz, 1H), 4.35 (d, J = 16.1 Hz, 1H), 2.43 (s, 3H), 1.87 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 167.9, 144.1,
136.2, 135.4, 131.1, 130.6, 129.5, 129.3, 127.7, 121.4, 102.4, 84.7,
47.3, 21.5, 20.3. HRMS (ESI) m/z: calcd for C19H19BrINO4SNa+ (M + Na)+, 581.9135; found, 581.9145.

2-Iodo-1-(4-methyl-N-phenethylphenylsulfonamido)allyl
Acetate (4qa)
Yield 72% (36.1 mg); Rf = 0.35 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 81.5–82.4 °C; IR (neat,
cm–1): 3457, 2383, 1755, 1635, 1272, 1166, 756; 1H NMR (400 MHz, CDCl3): δ 7.76 (d, J = 7.6 Hz, 2H), 7.29 (t, J = 7.1 Hz, 4H),
7.23 (d, J = 6.9 Hz, 1H), 7.16 (d, J = 7.4 Hz, 2H), 6.87 (s, 1H), 6.51 (s, 1H), 6.14 (s, 1H), 3.43–3.29
(m, 2H), 3.07–2.96 (m, 2H), 2.42 (s, 3H), 1.91 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
168.1, 144.0, 138.7, 136.2, 129.6, 128.7, 128.69, 128.6, 127.7, 126.5,
102.9, 84.7, 46.2, 37.3, 21.5, 20.4. HRMS (ESI) m/z: calcd for C20H22INO4SNa+ (M + Na)+, 522.0206; found, 522.0208.

1-(N-Butyl-4-methylphenylsulfonamido)-2-iodoallyl
Acetate (4ra)
Yield 48% (21.7 mg); Rf = 0.28 (SiO2; hexanes/ethyl
acetate, 10:1); yellow liquid; IR (neat, cm–1):
3466, 2991, 2389, 1644, 1164, 752; 1H NMR (400 MHz, CDCl3): δ 7.66 (d, J = 7.9 Hz, 2H), 7.23
(d, J = 7.9 Hz, 2H), 6.75 (s, 1H), 6.37 (s, 1H),
5.98 (s, 1H), 3.18–3.11 (m, 1H), 3.06–2.98 (m, 1H),
2.36 (s, 3H), 1.85 (s, 3H), 1.64–1.52 (m, 2H), 1.24–1.14
(m, 2H), 0.82 (t, J = 7.3 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.2, 143.8,
136.4, 129.5, 128.5, 127.7, 102.8, 84.7, 44.4, 32.5, 21.5, 20.4, 20.2,
13.6. HRMS (ESI) m/z: calcd for
C16H22INO4SNa+ (M + Na)+, 474.0206; found, 474.0207.

2-Iodo-1-(N-phenylmethylsulfonamido)allyl Acetate
(4sa)
Yield 74% (29.3 mg); Rf = 0.25 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 113.1–114.4 °C; IR (neat,
cm–1): 3760, 3448, 2939, 2384, 1756, 1653, 1216,
1020, 746, 701; 1H NMR (400 MHz, CDCl3): δ
7.51–7.47 (m, 2H), 7.42–7.40 (m, 3H), 7.12 (s, 1H),
6.14 (s, 1H), 5.80 (s, 1H), 3.04 (s, 3H), 2.23 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 168.2,
134.2, 131.2, 129.5, 129.2, 129.0, 101.2, 85.1, 39.9, 20.8. HRMS (ESI) m/z: calcd for C12H14INO4Na+ (M + Na)+, 417.9580; found,
417.9592.

2-Iodo-1-(N-phenylacetamido)allyl
Acetate (4ta)
Yield 81% (29.0 mg); Rf = 0.13 (SiO2; hexanes/ethyl
acetate,
10:1); brown liquid; IR (neat, cm–1): 3460, 2934,
2380, 1687, 1272, 1219, 1096, 1014, 823, 705; 1H NMR (400
MHz, CDCl3): δ 7.64 (s, 1H), 7.41 (s, 3H), 7.33 (s,
2H), 6.13 (s, 1H), 5.81 (s, 1H), 2.15 (s, 3H), 1.88 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ
171.2, 168.1, 137.6, 129.9, 129.1, 128.9, 128.4, 102.4, 80.3, 23.2,
20.7. HRMS (ESI) m/z: calcd for
C13H14INO3Na+ (M + Na)+, 381.9911; found, 381.9914.

2-Iodo-1-(2-oxooxazolidin-3-yl)allyl
Acetate (4ua)
Yield 48% (15.1 mg); Rf = 0.1 (SiO2; hexanes/ethyl
acetate, 10:1); colorless
liquid; IR (neat, cm–1): 2354, 2934, 2384, 1751,
1652, 1422, 1258, 1038, 927, 757; 1H NMR (400 MHz, CDCl3): δ 6.76 (s, 1H), 6.55 (s, 1H), 6.12 (s, 1H), 4.41
(t, J = 7.7 Hz, 2H), 3.60 (t, J =
7.8 Hz, 2H), 2.16 (s, 3H). 13C{1H} NMR (100
MHz, CDCl3): δ 168.0, 156.8, 128.7, 101.3, 80.6,
62.5, 39.9, 20.5. HRMS (ESI) m/z: calcd for C8H10INO4Na+ (M + Na)+, 333.9547; found, 333.9542.

(Z)-2-Iodo-3-(N-mesityl-4-methylphenylsulfonamido)allyl
Acetate (5)
Yield 56% (28.6 mg); Rf = 0.26 (SiO2; hexanes/ethyl
acetate, 10:1); white solid; mp 132.9–133.6 °C; IR (neat,
cm–1): 3454, 2937, 2382, 1625, 1088, 757; 1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 8.0 Hz, 2H), 7.56 (s, 1H), 7.31 (d, J = 7.9 Hz,
2H), 6.84 (s, 2H), 4.83 (s, 2H), 2.45 (s, 3H), 2.29 (s, 3H), 2.07
(s, 3H), 1.82 (s, 6H). 13C{1H} NMR (100 MHz,
CDCl3): δ 170.5, 144.6, 140.3, 139.6, 135.9, 133.0,
129.9, 129.5, 129.2, 128.9, 127.9, 73.6, 67.9, 21.6, 21.1, 21.0, 19.1.
HRMS (ESI) m/z: calcd for C21H24INO4SNa+ (M + Na)+, 536.0363; found, 536.0366.

(2S)-2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
2-((tert-Butoxycarbonyl)amino)-3-phenylpropanoate
(6, dr = 1:1)
Yield 51% (34.4 mg); Rf = 0.2 (SiO2; hexanes/ethyl
acetate, 10:1); colorless liquid; IR (neat, cm–1): 3438, 2991, 1718, 1500, 1368, 1169, 1084, 703, 666; 1H NMR (400 MHz, CDCl3): δ 7.57 (d, J = 7.6 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 7.34–7.26
(m, 12H), 7.23 (d, J = 5.1 Hz, 6H), 7.15 (t, J = 7.3 Hz, 6H), 5.99 (s, 1H), 5.85 (s, 1H), 5.67 (s, 1H),
5.65 (s, 1H), 5.30 (s, 2H), 4.85 (d, J = 7.9 Hz,
1H), 4.76 (d, J = 7.9 Hz, 1H), 4.49 (s, 2H), 3.14–3.05
(m, 2H), 3.04–2.96 (m, 2H), 2.41 (s, 3H), 2.39 (s, 3H), 1.43
(s, 9H), 1.36 (s, 9H). 13C{1H} NMR (100 MHz,
CDCl3): δ 169.9, 169.7, 154.9, 144.3, 144.2, 136.0,
135.8, 135.7, 135.6, 134.2, 131.5, 131.48, 129.9, 129.8, 129.5, 129.43,
129.4, 129.3, 129.2, 129.1, 128.8, 128.7, 128.69, 128.6, 128.2, 128.1,
127.2, 127.1, 99.9, 99.8, 86.1, 86.0, 80.2, 60.4, 54.2, 53.9, 53.5,
37.8, 37.6, 28.3, 28.2, 21.7, 21.6, 14.2. HRMS (ESI) m/z: calcd for C30H33IN2O6SNa+ (M + Na)+, 699.0996;
found, 699.1002.

(2S)-2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
2-Acetamido-3-phenylpropanoate (7, dr = 1:1)
Yield 47% (28.8 mg); Rf = 0.25 (SiO2; hexanes/ethyl acetate, 3:1); yellow liquid;
IR (neat, cm–1): 3403, 3303, 3075, 1760, 1688, 1500,
1082, 714, 703; 1H NMR (400 MHz, CDCl3): δ
7.59 (d, J = 8.0 Hz, 2H), 7.41 (d, J = 7.8 Hz, 2H), 7.37–7.30 (m, 4H), 7.30–7.22 (m, 12H),
7.17 (t, J = 7.5 Hz, 4H), 7.14–7.07 (m, 4H),
6.08–6.00 (m, 3H), 5.77 (s, 1H), 5.68 (s, 1H), 5.62 (s, 1H),
5.27 (s, 1H), 4.79 (dt, J = 14.4, 7.2 Hz, 2H), 3.13
(dd, J = 14.2, 5.2 Hz, 1H), 3.05 (d, J = 6.3 Hz, 2H), 3.02–2.97 (m, 1H), 2.40 (s, 3H), 2.37 (s,
3H), 1.95 (s, 3H), 1.88 (s, 3H). 13C{1H} NMR
(100 MHz, CDCl3): δ 170.1, 169.9, 169.7, 169.6, 144.4,
144.3, 135.9, 135.6, 135.5, 135.4, 134.1, 133.99, 131.6, 131.4, 130.0,
129.5, 129.4, 129.3, 129.29, 129.25, 129.2, 128.84, 128.8, 128.7,
128.6, 128.2, 128.1, 127.32, 127.3, 99.8, 99.5, 86.3, 86.2, 62.8,
52.9, 52.6, 37.4, 37.2, 22.9, 22.8, 21.7. HRMS (ESI) m/z: calcd for C27H27IN2O5SNa+ (M + Na)+, 641.0578;
found, 641.0575.

(2S)-2-Iodo-1-(4-methyl-N-phenylphenylsulfonamido)allyl
2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoate
(8, dr = 1:1)
Yield 51% (35.4 mg); Rf = 0.2 (SiO2; hexanes/ethyl
acetate, 3:1); colorless liquid; IR (neat, cm–1):
3402, 2991, 1700, 1520, 1168, 1068, 736, 701; 1H NMR (400
MHz, CDCl3): δ 7.56 (d, J = 7.8
Hz, 2H), 7.43 (d, J = 7.7 Hz, 2H), 7.33–7.30
(m, 3H), 7.26 (d, J = 7.5 Hz, 4H), 7.23–7.11
(m, 8H), 7.05 (d, J = 7.8 Hz, 2H), 6.98 (d, J = 7.8 Hz, 2H), 6.79–6.70 (m, 4H), 6.02 (br, 1H),
5.99 (s, 1H), 5.87 (s, 1H), 5.65 (s, 2H), 4.91–4.84 (m, 2H),
4.46–4.41 (m, 2H), 3.03–2.96 (m, 2H), 2.94–2.88
(m, 2H), 2.39 (s, 3H), 2.37 (s, 3H), 1.41 (s, 9H), 1.35 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ
170.0, 169.8, 155.1, 144.3, 144.28, 135.9, 135.8, 134.1, 131.6, 131.5,
130.5, 130.4, 130.0, 129.9, 129.6, 129.5, 129.4, 129.3, 129.2, 128.7,
128.6, 128.2, 128.1, 127.9, 127.8, 127.3, 127.23, 127.2, 121.7, 115.7,
99.9, 99.8, 86.1, 80.3, 60.5, 54.4, 54.2, 37.1, 36.8, 28.3, 28.2,
21.6, 21.58, 14.1. HRMS (ESI) m/z: calcd for C30H33IN2O7SNa+ (M + Na)+, 715.0945; found, 715.0949.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.9b02712.Copies of 1H and 13C NMR spectra
for all products and X-ray structural information for 4ia (PDF)

Crystal
data for 4ia (CIF)



Supplementary Material
ao9b02712_si_001.pdf

 ao9b02712_si_002.cif

 The authors declare no
competing financial interest.

Acknowledgments
This work was financially
supported by the Project
of Science and Technology Department of Sichuan Province (2018JY0226)
and the Fundamental Research Funds of Central Universities, Southwest
Minzu University (2018NZD05).
==== Refs
References
a Ankisetty S. ; ElSohly H. N. ; Li X.-C. ; Khan S. I. ; Tekwani B. L. ; Smillie T. ; Walker L. 
Aromatic constituents
of Uvaria grandiflora . J. Nat. Prod. 
2006 , 69 , 692 –694 . 10.1021/np050500b .16643056  b Jogalekar A. S. ; Kriel F. H. ; Shi Q. ; Cornett B. ; Cicero D. ; Snyder J. P. 
The Discodermolide Hairpin Structure Flows from Conformationally
Stable Modular Motifs . J. Med. Chem. 
2010 , 53 , 155 –165 . 10.1021/jm9015284 .19894728  c Macabeo A. P. G. ; Letada A. G. ; Budde S. ; Faderl C. ; Dahse H. M. ; Franzblau S. G. ; Alejandro G. J. D. ; Pierens G. K. ; Garso M. J. 
Antitubercular
and Cytotoxic Chlorinated seco-Cyclohexenes from Uvaria alba . J. Nat. Prod. 
2017 , 80 , 3319 –3323 . 10.1021/acs.jnatprod.7b00679 .29172496 
Selected examples:

a Chen S. ; Wei W.-X. ; Wang J. ; Xia Y. ; Shen Y. ; Wu X.-X. ; Jing H. ; Liang Y.-M. 
Palladium-Catalyzed
Isocyanide Insertion with Allylic Esters: Synthesis of N-(But-2-enoyl)-N-(tert-butyl)benzamide
Derivatives via Intramolecular Acyl Transfer Termination . Adv. Synth. Catal. 
2017 , 359 , 3538 –3544 . 10.1002/adsc.201700765 . b Kim S. W. ; Wurm T. ; Brito G. A. ; Jung W.-O. ; Zbieg J. R. ; Stivala C. E. ; Krische M. J. 
Hydroamination
versus Allylic Amination in Iridium-Catalyzed Reactions of Allylic
Acetates with Amines: 1,3-Aminoalcohols via Ester-Directed Regioselectivity . J. Am. Chem. Soc. 
2018 , 140 , 9087 –9090 . 10.1021/jacs.8b05683 .29989803  c Liu Y.-J. ; Ding Y.-L. ; Niu S.-S. ; Ma J.-T. ; Cheng Y. 
N-Heterocyclic Carbene/Palladium
Cascade Catalysis: Construction of 2,2-Disubstitiuted Benzofuranones
from the Reaction of 3-(2-Formylphenoxy) propenoates with Allylic
Esters . J. Org. Chem. 
2018 , 83 , 1913 –1923 . 10.1021/acs.joc.7b02849 .29319303  d Zhou Y. ; Wang H. ; Liu Y. ; Zhao Y. ; Zhang C. ; Qu J. 
Iron-catalyzed boration of allylic esters: an efficient approach
to allylic boronates . Org. Chem. Front. 
2017 , 4 , 1580 –1585 . 10.1039/c7qo00228a .
a Cannon J. S. ; Kirsch S. F. ; Overman L. E. 
Catalytic Asymmetric
Synthesis of Chiral Allylic Esters . J. Am. Chem.
Soc. 
2010 , 132 , 15185 –15191 . 10.1021/ja106685w .20942420  b Geurts K. ; Fletcher S. P. ; Feringa B. L. 
Copper catalyzed
asymmetric synthesis of chiral allylic esters . J. Am. Chem. Soc. 
2006 , 128 , 15572 –15573 . 10.1021/ja065780b .17147350  c Kanbayashi N. ; Onitsuka K. 
Enantioselective Synthesis of Allylic
Esters via Asymmetric Allylic Substitution with Metal Carboxylates
Using Planar-Chiral Cyclopentadienyl Ruthenium Catalysts . J. Am. Chem. Soc. 
2010 , 132 , 1206 –1207 . 10.1021/ja908456b .20052978  d Tang J. ; Zhao S. ; Wei Y. ; Quan Z. ; Huo C. 
CBr4 promoted intramolecular
aerobic oxidative dehydrogenative arylation of aldehydes: application
in the synthesis of xanthones and fluorenones . Org. Biomol. Chem. 
2017 , 15 , 1589 –1592 . 10.1039/c7ob00080d .28134379  e Xiang J. ; Orita A. ; Otera J. 
Fluorous biphasic esterification
directed towards ultimate atom efficiency . Angew.
Chem., Int. Ed. 
2002 , 41 , 4117 –4119 . 10.1002/1521-3773(20021104)41:21<4117::aid-anie4117>3.0.co;2-4 .
Selected examples:

a Chen M. S. ; Prabagaran N. ; Labenz N. A. ; White M. C. 
Serial ligand catalysis:
A highly selective allylic C-H oxidation . J.
Am. Chem. Soc. 
2005 , 127 , 6970 –6971 . 10.1021/ja0500198 .15884938  b Chen M. S. ; White M. C. 
A sulfoxide-promoted, catalytic method
for the regioselective synthesis of allylic acetates from monosubstituted
olefins via C-H oxidation . J. Am. Chem. Soc. 
2004 , 126 , 1346 –1347 . 10.1021/ja039107n .14759185  c Gormisky P. E. ; White M. C. 
Synthetic Versatility in C-H Oxidation: A Rapid Approach
to Differentiated Diols and Pyrans from Simple Olefins . J. Am. Chem. Soc. 
2011 , 133 , 12584 –12589 . 10.1021/ja206013j .21744821  d Kondo H. ; Yu F. ; Yamaguchi J. ; Liu G. ; Itami K. 
Branch-Selective Allylic C-H Carboxylation of Terminal
Alkenes by Pd/sox Catalyst . Org. Lett. 
2014 , 16 , 4212 –4215 . 10.1021/ol5019135 .25068764  e Takenaka K. ; Akita M. ; Tanigaki Y. ; Takizawa S. ; Sasai H. 
Enantioselective
Cyclization of 4-Alkenoic Acids via an Oxidative Allylic C-H Esterification . Org. Lett. 
2011 , 13 , 3506 –3509 . 10.1021/ol201314m .21657245  f Fraunhoffer K. J. ; Prabagaran N. ; Sirois L. E. ; White M. C. 
Macrolactonization via hydrocarbon
oxidation . J. Am. Chem. Soc. 
2006 , 128 , 9032 –9033 . 10.1021/ja063096r .16834366 
Selected examples:

a García-Cabeza A. L. ; Marín-Barrios R. ; Moreno-Dorado F. J. ; Ortega M. J. ; Massanet G. M. ; Guerra F. M. 
Allylic Oxidation of Alkenes Catalyzed by a Copper-Aluminum
Mixed Oxide . Org. Lett. 
2014 , 16 , 1598 –1601 . 10.1021/ol500198c .24597600  b Sadjadi S. ; Samadi S. ; Samadi M. 
Cu(CH3CN)(4)PF6 immobilized on halloysite as efficient heterogeneous catalyst for
oxidation of allylic C-H bonds in olefins under mild reaction condition . Res. Chem. Intermed. 
2019 , 45 , 2441 –2455 . 10.1007/s11164-019-03745-z . c Tan Q. ; Hayashi M. 
Novel N,N-Bidentate
Ligands for Enantioselective Copper(I)-Catalyzed Allylic Oxidation
of Cyclic Olefins . Adv. Synth. Catal. 
2008 , 350 , 2639 –2644 . 10.1002/adsc.200800457 . d Wang C.-Y. ; Song R.-J. ; Wei W.-T. ; Fan J.-H. ; Li J.-H. 
Copper-catalyzed
oxidative coupling of acids with alkanes involving dehydrogenation:
facile access to allylic esters and alkyl alkenes . Chem. Commun. 
2015 , 51 , 2361 –2363 . 10.1039/c4cc09393c . e Xiong M.-F. ; Ali A. ; Akram W. ; Zhang H. ; Si L.-P. ; Liu H.-Y. 
Copper porphyrin
as efficient catalysts for esterification of allyl sp(3) C-H bond
with carboxylic acid . Catal. Commun. 
2019 , 125 , 93 –97 . 10.1016/j.catcom.2019.04.001 . f Zhang B. ; Zhu S.-F. ; Zhou Q.-L. 
Copper-catalyzed
enantioselective allylic oxidation of acyclic olefins . Tetrahedron Lett. 
2013 , 54 , 2665 –2668 . 10.1016/j.tetlet.2013.03.046 . g Zhou J. ; Jin C. ; Li X. ; Su W. 
Copper-catalyzed oxidative esterification of unactivated
C(sp(3))-H bonds with carboxylic acids via cross dehydrogenative coupling . RSC Adv. 
2015 , 5 , 7232 –7236 . 10.1039/c4ra14586k . h Zhu N. ; Qian B. ; Xiong H. ; Bao H. 
Copper-catalyzed
regioselective allylic oxidation of olefins via C-H activation . Tetrahedron Lett. 
2017 , 58 , 4125 –4128 . 10.1016/j.tetlet.2017.09.047 .
Lu B. ; Zhu F. ; Wang D. ; Sun H. ; Shen Q. 
Iron-catalyzed esterification
of allylic sp(3) C-H bonds with carboxylic acids: Facile access to
allylic esters . Tetrahedron Lett. 
2017 , 58 , 2490 –2494 . 10.1016/j.tetlet.2017.05.039 .
a Koschker P. ; Kähny M. ; Breit B. 
Enantioselective Redox-Neutral
Rh-Catalyzed Coupling of Terminal Alkynes with Carboxylic Acids Toward
Branched Allylic Esters . J. Am. Chem. Soc. 
2015 , 137 , 3131 –3137 . 10.1021/jacs.5b01131 .25667963  b Lumbroso A. ; Abermil N. ; Breit B. 
Atom economic macrolactonization
and lactonization via redox-neutral rhodium-catalyzed coupling of
terminal alkynes with carboxylic acids . Chem.
Sci. 
2012 , 3 , 789 –793 . 10.1039/c2sc00812b . c Lumbroso A. ; Koschker P. ; Vautravers N. R. ; Breit B. 
Redox-Neutral Atom-Economic Rhodium-Catalyzed Coupling of Terminal
Alkynes with Carboxylic Acids Toward Branched Allylic Esters . J. Am. Chem. Soc. 
2011 , 133 , 2386 –2389 . 10.1021/ja1108613 .21291216 
Al-Masum M. ; Yamamoto Y. 
Palladium-catalyzed
hydrocarboxylation of allenes . J. Am. Chem.
Soc. 
1998 , 120 , 3809 –3810 . 10.1021/ja974223+ .
Kim I. S. ; Krische M. J. 
Iridium-catalyzed
hydrocarboxylation of 1,1-dimethylallene:
Byproduct-free reverse prenylation of carboxylic acids . Org. Lett. 
2008 , 10 , 513 –515 . 10.1021/ol702914p .18181640 
Koschker P. ; Lumbroso A. ; Breit B. 
Enantioselective
Synthesis of Branched
Allylic Esters via Rhodium-Catalyzed Coupling of Allenes with Carboxylic
Acids . J. Am. Chem. Soc. 
2011 , 133 , 20746 –20749 . 10.1021/ja210149g .22111875 
Shi E. ; Shao Y. ; Chen S. ; Hu H. ; Liu Z. ; Zhang J. ; Wan X. 
Tetrabutylammonium Iodide Catalyzed
Synthesis of Allylic Ester with tert-Butyl Hydroperoxide as an Oxidant . Org. Lett. 
2012 , 14 , 3384 –3387 . 10.1021/ol3013606 .22731787 
a Lu T. ; Hayashi R. ; Hsung R. P. ; DeKorver K. A. ; Lohse A. G. ; Song Z. ; Tang Y. 
Synthesis
of amido-spiro 2.2 pentanes via Simmons-Smith cyclopropanation of
allenamides . Org. Biomol. Chem. 
2009 , 7 , 3331 –3337 . 10.1039/b908205k .19641792  b Lu T. ; Lu Z. ; Ma Z.-X. ; Zhang Y. ; Hsung R. P. 
Allenamides:
A Powerful and Versatile Building Block in Organic Synthesis . Chem. Rev. 
2013 , 113 , 4862 –4904 . 10.1021/cr400015d .23550917  c Standen P. E. ; Kimber M. C. 
Cycloaddition chemistry of allenamides . Curr. Opin. Drug Discovery Dev. 
2010 , 13 , 645 –657 . d Wei L.-l. ; Xiong H. ; Hsung R. P. 
The emergence of
allenamides in organic synthesis . Acc. Chem.
Res. 
2003 , 36 , 773 –782 . 10.1021/ar030029i .14567711 
a Li H.-H. ; Li X.-X. ; Zhao Z.-G. ; Lin C.-B. ; Ma T. ; Sun C.-Y. ; Yang B.-W. ; Fu X.-L. 
An intermolecular iodoamination of allenamides with sulfonamides
mediated by N-iodosuccinimide . Tetrahedron Lett. 
2016 , 57 , 4640 –4644 . 10.1016/j.tetlet.2016.09.020 . b Li H. ; Li X. ; Zhao Z. ; Ma T. ; Sun C. ; Yang B. 
Intermolecular iodofunctionalization of allenamides
with indoles, pyrroles, and furans: synthesis of iodine-substituted
Z-enamides . Chem. Commun. 
2016 , 52 , 10167 –10170 . 10.1039/c6cc05046h . c Li H.-H. ; Li X.-X. ; Zhao Z.-G. ; Yuan X. ; Sun C.-Y. 
Regioselective 1,2-addition of allenamides with N-haloimides:
synthesis of 2-halo allylic aminal derivatives . Org. Biomol. Chem. 
2017 , 15 , 4005 –4013 . 10.1039/c7ob00882a .28443882  d Li Y. ; Luo G. L. ; Li X. X. ; Zhao Z. G. 
NIS-Mediated
intermolecular hydroamination of allenamides with imidazole heterocycles:
a facile protocol for the synthesis of allylic N,N-acetals . New J. Chem. 
2018 , 42 , 16940 –16947 . 10.1039/c8nj03641a .
Yuan X. ; Re He Man X. J. A. T. ; Li X.-X. ; Zhao Z.-G. 
Regioselective 1,2-additions
of alcohols to allenamides mediated by N-Iodosuccinimide: Synthesis
of N,O-aminals . Tetrahedron 
2018 , 74 , 5674 –5682 . 10.1016/j.tet.2018.07.045 .
4ia’s molecular
structure
was confirmed by its X-ray diffraction. Other product’s structure
was also deduced from 4ia. CCDC 1937962 contains the
supplementary crystallographic data for compound 4ia.


a Suárez-Pantiga S. ; Hernández-Díaz C. ; Rubio E. ; González J. M. 
Intermolecular [2+2] reaction of
N-allenylsulfonamides with vinylarenes: enantioselective gold(I)-catalyzed
synthesis of cyclobutane derivatives . Angew.
Chem., Int. Ed. 
2012 , 51 , 11552 –11555 . 10.1002/anie.201206461 . b Li X. ; Zhao Z. ; Ma T. ; Li H. ; Sun C. 
Intermolecular Hydroalkoxylation of N-Allenyl Sulfonamides with Oximes
Catalyzed by Cationic Gold(I) Salts . Synthesis 
2016 , 48 , 1011 –1018 . 10.1055/s-0035-1560399 . c Chakrabarty I. ; Inamdar S. M. ; Akram M. O. ; Gade A. B. ; Banerjee S. ; Bera S. ; Patil N. T. 
[3+2]-Annulation
of platinum-bound azomethine ylides with distal C=C bonds of N-allenamides . Chem. Commun. 
2017 , 53 , 196 –199 . 10.1039/c6cc07874e . d Yang B. ; Zhai X. ; Feng S. ; Hu D. ; Deng Y. ; Shao Z. 
Organocatalyzed Intermolecular Asymmetric
Allylic Dearomatization of Both alpha- and beta-Naphthols . Org. Lett. 
2019 , 21 , 330 –334 . 10.1021/acs.orglett.8b03934 .30585495  e Jia M. ; Cera G. ; Perrotta D. ; Monari M. ; Bandini M. 
Taming gold(I)-counterion interplay in the de-aromatization
of indoles with allenamides . Chemistry 
2014 , 20 , 9875 –9878 . 10.1002/chem.201403155 .25044346  f Li X.-X. ; Zhu L.-L. ; Zhou W. ; Chen Z. 
Formal Intermolecular
[2+2] Cycloaddition Reaction of Alleneamides with Alkenes via Gold
Catalysis . Org. Lett. 
2012 , 14 , 436 –439 . 10.1021/ol202703a .22201372  g Zheng W. F. ; Sun G. J. ; Chen L. ; Kang Q. 
Enantioselective Synthesis
of trans-Vicinal Diamines viaRhodium-Catalyzed [2+2] Cycloaddition
of Allenamides . Adv. Synth. Catal. 
2018 , 360 , 1790 –1794 . 10.1002/adsc.201800021 . h Zheng W.-F. ; Bora P. P. ; Sun G.-J. ; Kang Q. 
Rhodium-Catalyzed
Regio- and Stereoselective [2+2] Cycloaddition of Allenamides . Org. Lett. 
2016 , 18 , 3694 –3697 . 10.1021/acs.orglett.6b01731 .27403894  i Li Y. ; Chen J. ; Qiu R. ; Wang X. ; Long J. ; Zhu L. ; Au C.-T. ; Xu X. 
Cesium hydroxide-catalyzed
isomerization of terminal alkynes for the synthesis of O-allenes and
N-allenes . Tetrahedron Lett. 
2015 , 56 , 5504 –5507 . 10.1016/j.tetlet.2015.08.016 . j Wei L.-L. ; Mulder J. A. ; Xiong H. ; Zificsak C. A. ; Douglas C. J. ; Hsung R. P. 
Efficient preparations of novel ynamides
and allenamides . Tetrahedron 
2001 , 57 , 459 –466 . 10.1016/s0040-4020(00)01014-0 .

